The useful family-office AI question is not “Who is interested in artificial intelligence?” It is which investing team can fund this kind of company, with this evidence, at this stage.
This guide compares 15 family-office and family-backed investment routes for AI startups. It separates explicit AI theses from broader technology strategies with documented AI-company experience. Some platforms also manage outside capital or corporate venture strategies; the profiles name that structure rather than call every investor a single-family office.
Match AI capital to the actual business
Start with the product category: enterprise software, enabling infrastructure, physical automation, healthcare or scientific discovery. Then check direct-company investing, current entry stage and geography. “AI” alone does not explain the buyer, defensibility or capital needed.
- Pre-seed: explain the insight, prototype or validated problem, and the next experiment.
- Seed: connect product performance to a real user and show the evidence that the business is becoming repeatable.
- Series A and later: prepare commercial or scientific evidence appropriate to the investor's stated strategy. Do not assume that a famous early portfolio investment describes today's entry policy.
Compare 15 AI family-capital routes
Sources reviewed November 13, 2026. This is a research shortlist, not a ranking or a promise of an open allocation. Scroll the table horizontally on mobile. A documented portfolio company is labeled as experience, not treated as an unrestricted current mandate.
| Investor | Product focus | Stage or route | Geographic filter |
|---|---|---|---|
| Reimann Investors | B2B software, AI and fintech | Seed and Series A; validated customer value | Germany, Austria and Switzerland |
| Halfmeyer Ventures | Software-led health tech, AI, commerce and automation | Pre-seed and seed; product, prototype or validated problem | Europe and beyond; no Berlin-residence requirement |
| Adeline Arts & Science | Frontier technology, AI, science, climate and health | Pre-seed through Series A | UK and European sourcing, including DACH; global outlook |
| Motier Ventures | Technology, including a documented AI portfolio | Early company angel investment and follow-on | Paris-based; confirm geography for the company |
| Keller Capital | Technology, including AI-native companies | Early and growth-stage technology; deal-specific | Austin-based; company eligibility is separate |
| Park South Capital | Biotechnology, fintech, AI and technology-enabled businesses | Seed and Series A; stated exclusions apply | Global with named excluded markets; check the full list |
| Raptor Group | Technology, AI, robotics, healthcare and other stated sectors | Early stage through growth; strategy-specific | Boston-based platform; company-market scope must be confirmed |
| PremjiInvest | Healthcare, life sciences and technology-enabled businesses | Earliest stages through public markets; strategy-specific | India and US activity; confirm company and vehicle scope |
| AlFardan Ventures | Digital health, biotechnology and AI-enabled diagnostics | Early through growth | UAE launchpad, Middle East and global opportunities |
| Wille Finance | ICT, including documented AI-software holdings; not AI-only | Venture: Series A and B; buyout is separate | European venture strategy; DACH buyout scope is distinct |
| B2V Ventures | Sector-agnostic; documented AI and AI-enabled companies | Multi-stage company investing | India and overseas; confirm company eligibility |
| Arkin Capital | Digital-health AI; broader biotech strategy is separate | Early and later biotech; digital-health strategies differ | Israel-rooted platform; confirm company eligibility |
| Gloucester Ventures | AI-enabled biotech tools, platforms and precision diagnostics | Pre-seed and seed | US, UK and Israel |
| Aglaé Ventures | Technology; current portfolio includes AI companies | First conviction through pre-IPO; team-specific | Global outlook; confirm relevant team and company market |
| CE-Ventures | Consumer, deep tech and biotech; current AI-company investments | Early through later-stage companies | US, MENA, India and Southeast Asia |
Read provider criteria and approach routes
1. Reimann Investors
Family-office-backed venture platform. Reimann's current startup focus includes AI-enabled B2B software at seed and Series A in DACH. Explain the customer value already validated, not simply which foundation model the product uses. Its published stage and market filters are more useful than a general family-office label.
Founder route: Pitch to us route. Official criteria.
2. Halfmeyer Ventures
Family office and venture studio. Halfmeyer looks for early software-led companies with a working product, prototype or validated problem. AI is relevant within that operating-company remit, not as a reason to skip evidence. Hardware-only or idea-only companies should not assume the same fit.
Founder route: Public cold-pitch form. Official criteria · Supporting official evidence.
3. Adeline Arts & Science
Family office. Adeline explicitly combines AI and frontier-science interests with pre-seed-to-Series-A family capital. Show the technical advantage and a credible first use case. A company using AI as an incidental feature still needs to explain why the business fits the investment thesis.
Founder route: Pitch us form on the official site. Official criteria.
4. Motier Ventures
Venture family office. Motier's current early-stage portfolio includes AI companies, and its family-office model supports first investments and follow-ons. Treat the named companies as evidence of experience, not an open invitation to every AI category. Describe the product, customer and next proof point.
Founder route: Official contact route on the site. Official criteria.
5. Keller Capital
Single-family office. Keller identifies AI-native companies within its venture and growth strategy. Put the business model and operating milestone first, then explain where AI is essential. Select the direct-company route rather than its separate real-estate, credit or fund-investment activities.
Founder route: Submit a Deal form. Official criteria.
6. Park South Capital
Single-family office. Park South names AI within its seed and Series A company focus. Geography is a real filter: it publishes market exclusions, so a broad global description is not enough. Its submission guidance asks founders not to provide confidential information or trade secrets.
Founder route: Submit a business opportunity form. Official criteria.
7. Raptor Group
Investment firm backed by Jim Pallotta's family office. Raptor explicitly includes AI and robotics in a wider technology strategy backed by family capital. This makes it worth researching for businesses crossing software and physical systems. Match the relevant team and round; do not infer a standard check or universal geography from the portfolio.
Founder route: Official Contact Us route. Official criteria.
8. PremjiInvest
Permanent-capital investment platform. PremjiInvest's current themes include vertical AI, infrastructure, physical AI and AI in biology. Those are different evidence stories. A founder should identify which theme fits the actual product and explain the proprietary data, workflow or scientific advantage rather than rely on a broad AI claim.
Founder route: Official investment team and contact. Official criteria.
9. AlFardan Ventures
Family-office and strategic investment arm. AlFardan names AI, machine learning, automation and data infrastructure among its investment areas. An enterprise platform, industrial AI system and diagnostic application should be framed differently. Its UAE launchpad and global activity do not mean every market or stage automatically qualifies.
Founder route: Official Contact form. Official criteria · Supporting official evidence.
10. Wille Finance
Single-family office. Wille's European Series A and B venture remit covers ICT, and its published portfolio includes AI software such as Yseop. That supports research into relevant applications, not a claim that Wille is an AI-only investor. Show commercial evidence appropriate to the stated stage.
Founder route: Private equity team contact on the official page. Official criteria.
11. B2V Ventures
Single-family office. B2V's current company portfolio includes AI-enabled businesses such as Miko and Field Assist within a multi-stage, sector-agnostic strategy. Distinguish that direct-company activity from its fund investments. Explain the customer and differentiated value proposition rather than treating a broad portfolio as a specific open AI mandate.
Founder route: Pitch submission linked by the official site. Official criteria.
12. Arkin Capital
Family-origin investment platform with external-capital strategies. Arkin's digital-health activity includes Eleos, whose published company profile describes AI for behavioral-health workflows. This is a healthcare-specific research route, not evidence of a broad foundation-model mandate. Identify the relevant health-investment team and show the clinical-workflow and commercial context.
Founder route: Official team and company contact. Official criteria · Supporting official evidence.
13. Gloucester Ventures
Single-family office. Gloucester explicitly discusses generative and agentic AI in biotech tools and precision diagnostics. Its pre-seed and seed focus is constrained by sector and US, UK or Israeli scope. A general enterprise AI product is not an equivalent match.
Founder route: Pitch Your Startup on the official site. Official criteria.
14. Aglaé Ventures
Agache-backed global technology investment platform. Aglaé identifies its backing by Agache and a company lifecycle from early conviction to pre-IPO. Its current portfolio includes AI businesses. The founder's task is to match the product and stage to a partner, not assume a family-backed platform has one undifferentiated AI allocation.
Founder route: Official firm and investment-team information. Official criteria.
15. CE-Ventures
Corporate venture arm of a family business group. Crescent Enterprises' venture arm documents a direct-company strategy and AI-company investments alongside venture funds. It is corporate venture capital within a family business group, not a traditional single-family office. Identify the company-investment route and the specific strategic relevance.
Founder route: Official Crescent Enterprises company contact. Official criteria · Supporting official evidence.
Give the investor more than an AI label
A strong first brief connects four things: the customer's job, the product advantage, the evidence and the next milestone. Explain where the model comes from and what the company itself owns or does uniquely. An API dependency is not automatically a weakness, but it is not a proprietary model either.
For enterprise AI, make the workflow and buyer concrete. For physical AI, include prototype and deployment evidence. For AI in biology or healthcare, distinguish model performance from experimental or clinical evidence. Keep confidential data and trade secrets out of a first submission unless an appropriate process has been agreed.
How do family offices use AI?
That question can mean something different from this guide. A family office may use AI for research or operations without investing in AI startups. Here, inclusion depends on an actual company-investment strategy and explicit AI interest or documented AI-company experience. It does not depend on the investor using an AI tool internally.
A worked shortlist for an AI workflow company
Fictional example: Harbor Ledger sells AI-assisted document review to finance teams and is raising seed capital. It has a working product and early customer evidence. The founders investigate software-oriented early-stage routes such as Halfmeyer, Reimann if DACH eligibility fits, and Keller's AI-native remit.
They do not add Gloucester simply because the software uses an AI model; its biotech-tools mandate is a different job. They treat Wille's Series A/B remit as a later-stage research option, not force a seed pitch into it. The result is a shorter, better-supported conversation queue.
Copy the AI investor-fit worksheet
Keep the evidence and the relationship in one place. In Finta, a shortlist can carry the source, fit notes, contact context and next step instead of becoming another static AI investor spreadsheet.
AI FAMILY-CAPITAL FIT WORKSHEET
Company / actual customer and job:
AI role: core product / enabling feature / infrastructure / physical system / science
What the company owns or does uniquely:
Product, customer or scientific evidence achieved:
Round / next milestone / work financed:
Investor and actual direct-company team:
Evidence type: explicit AI thesis / documented AI-company experience
Sector, stage and country conditions:
Source URL / date / unknowns:
Relevant public approach route:
Non-confidential first question:
Relationship owner / next action / review date:Ask Aurora, Claude or Codex to review your shortlist
Supply your facts and the official sources. Review the result before acting; this is a research aid, not automatic outreach.
Help me evaluate an AI-startup family-capital shortlist from the official sources I provide.
Company facts: [customer, product, AI role, defensibility, geography, stage, evidence and next milestone].
Separate investors with an explicit AI thesis from broader investors with documented AI-company experience. Distinguish investing in AI companies from using AI internally, and direct company capital from fund allocations. Check sector, entry stage, geography and public approach route. Do not infer an unrestricted current mandate from one portfolio company. Mark unknowns and eliminate weak matches. Return a concise research queue with evidence, open questions and the best next action. Do not send outreach or promise funding.Methodology and related guides
The Finta Editorial Team reviewed current investor-controlled criteria, strategy, company and portfolio pages. We count each platform once and label traditional family offices, family-origin venture platforms and corporate investment arms separately. A current website is not proof of a remaining investment allocation; founders should confirm fit with the relevant team.
Use the family-office direct-investment hub and pitch guide for the broader approach. Compare pre-seed AI investors or AI investors that lead seed rounds when the entry stage or lead role is the primary decision.
This is general research and organizational information, not personalized financial, legal or tax advice.